Trial Profile
A Phase I, Open-label, Study of the Absorption, Metabolism and Excretion, of [14C]-Benznidazole (BNZ) Following a Single Oral Dose in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Nov 2018
Price :
$35
*
At a glance
- Drugs Benznidazole (Primary)
- Indications Chagas disease
- Focus Pharmacokinetics
- Sponsors Exeltis
- 21 Nov 2018 New trial record